ICON (ICLR) total debt

Total debt · fiscal 2025
$3.56B

ICON (ICLR) carried total debt of $3.56B at the end of fiscal 2025 (December 31, 2025). That is 1.3% lower than the $3.60B of fiscal 2024. Figures as of 18 Nov 2026, 04:03 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$3.56B
Change on fiscal 2024
−1.3%
Growth, 5 years
+59.1% a year
Highest on record
$5.50Bfiscal 2021
Lowest on record
$348.48Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

ICON total debt, in more detail

Over the five fiscal years to 2025 total debt grew at a compound 59.1% a year. Across the 6 fiscal years on record (2020–2025), the highest was $5.50B in fiscal 2021 and the lowest $348.48M in fiscal 2020.

Total debt was 0.4× shareholders' equity at the end of fiscal 2025.

History · 6 fiscal years

Total debt by fiscal year

ICON total debt, year by year

ICON (ICLR) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$3.56B 1.3% down0.4×
2024$3.60B 8.5% down0.4×
2023$3.94B 18.5% down0.4×
2022$4.83B 12.2% down0.6×
2021$5.50B 1,478.6% up0.7×
2020$348.48M—0.2×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of ICON and comparable companies
CompanyTotal debtFiscal year
Neurocrine Biosciences NBIX$415.30M2025
Ascendis Pharma ASND€871.79M2025
ICON ICLR$3.56B2025
Solventum SOLV$5.04B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ICLR

ICON, figure by figure

ICON (ICLR) overview: price, valuation and scorecardAll health care companies by market value

ICON total debt: questions and answers

How much debt does ICON have?

ICON (ICLR) carried total debt of $3.56B at the end of fiscal 2025 (December 31, 2025). That is 1.3% lower than the $3.60B of fiscal 2024.

What is the growth rate of ICON's total debt?

Over the five fiscal years to 2025 total debt grew at a compound 59.1% a year.

What are the highest and lowest total debt figures on record for ICON?

Across the 6 fiscal years on record (2020–2025), the highest was $5.50B in fiscal 2021 and the lowest $348.48M in fiscal 2020.

How does ICON's debt compare with its equity?

Total debt was 0.4× shareholders' equity at the end of fiscal 2025.

How is ICON's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ICON (ICLR) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/ICLR/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.